當前位置：   首頁 > 需求大廳

 >  特色服務 

標題：重金求購葡萄糖酸鈣 美國最新藥典 USP41 原料藥原版原文 詳細要求：葡萄糖酸鈣 美國最新版藥典標準 USP41 需求名稱：葡萄糖酸鈣 美國最新藥典 USP41 原料藥原版原文 具體要求：葡萄糖酸鈣 美國最新藥典 USP41 原料藥原版原文 要求時間：請在2019年2月16日前 交稿方式：直接點擊交稿在線交稿就是了，我會每天過來看的，謝謝各位藥智的戰友們   [更多]

求助BP最新版本的 moxidectin injection monograph.   [更多]

求DOF期刊2018年10-12期文獻   [更多]

1、 Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 2、 Minerva Gastroenterol Dietol. 2015 Dec;61(4):273-92. Probiotics in digestive diseases: focus on Lactobacillus GG. Pace F1, Pace M, Quartarone G. 3、 El-Safory N S，Fazary A E，Lee C-K. Hyaluronidases, a group of glycosidases: current and future perspectives[J]. Carbohydrate Polymers, 2010, 81(2): 165-181. 4、 Perng CK, Wang YJ, Tsi CH，et al. In vivo angiogenesis effect of porous collagen scaffold with hyaluronic acid oligosaccharides. J Surg Res，2011，168(1) : 9-15. 5、 Termeer C, Sleeman JP, Simon JC. Hyaluronan- magic glue for the regulation of the immune response [J]. Trends Immunol, 2003, 24(3):112- 114. 6、 https://www.eurekalert.org/pub_releases/2019-01/uob-bri010819.php 7、 Collection of Czechoslovak Chmical Communication, 1987, vol47, #1, P65-71. 8、 Phloroglucinol in irritable bowel syndrome 9、 Phosphodiesterase 5 inhibitors in male sexual dysfunction 10、 The Response to Vedolizumab in Chronic Granulomatous Disease   [更多]

標題：重金求購“DTaP/IPV”《 BP2015 》的藥典標準一份. 詳細要求： 需求名稱：Diphtheria, Tetanus, Pertussis (Acellular Component) and Inactivated Poliomyelitis Vaccine, Adsorbed的藥典標準 具體要求：英文原文電子版，最好有中文 要求時間：請在2019年1月22日之前 交稿方式：直接點擊交稿在線交稿就是了，我會每天過來看的，謝謝各位藥智的戰友們   [更多]

求購：USP Monographs: Temozolomide for Injection”《 USP41-NF36 》的美國藥典（USP41-NF36 ）標準一份   [更多]

求購“USP Monographs: Teriparatide Injection”《 USP41-NF36 》的藥典標準一份.   [更多]

“Formulated Preparations: Specific Monographs: Inositol Nicotinate Tablets”《 BP2019 》的藥典標準一份.   [更多]

最好能附帶原料藥標準   [更多]

1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels 2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components 3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage 4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors 5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure 6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion 7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema 8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites 9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease 10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement 11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print] 12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print] 13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines 15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing 16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms 17. On the hydrolytic behavior of tinidazole, metronidazole,   [更多]